Gonzalez Constance, Sun Meng, Morand Aurélie, Minodier Philippe, Leone Marc, Dubus Jean-Christophe, Vitte Joana, Michel Moïse
Aix-Marseille Université, Assistance publique-Hôpitaux de Marseille (AP-HM), Hôpital Timone, Service de Pneumologie et allergologie pédiatrique, Marseille, France.
Aix-Marseille Université, MEPHI, Institut Hospitalo-Universitaire Méditerranée Infection, Marseille, France.
J Allergy Clin Immunol Glob. 2025 Jun 24;4(3):100524. doi: 10.1016/j.jacig.2025.100524. eCollection 2025 Aug.
Dynamic measurement of serum acute (sAT) and baseline (sBT) tryptase confirms mast cell degranulation during systemic hypersensitivity reactions, provided timing and interpretation are appropriate. The current consensus formula requires sAT greater than a personalized cutoff value [sAT > (1.2 × sBT) + 2]. Only a few studies have investigated its diagnostic performance in children.
We assessed the diagnostic accuracy of the consensus formula and alternative algorithms for interpreting tryptase levels in pediatric patients with suspected anaphylaxis.
Medical records of suspected anaphylaxis referred to the pediatric emergency department of the University Hospitals of Marseille (France) from 2011 to 2020 were retrospectively reviewed. Clinical and laboratory data, including total tryptase and allergy evaluations, were collected. Anaphylaxis was defined as a sudden-onset, perceived life-threatening systemic reaction at the time of physician assessment. Inclusion criteria were suspected anaphylaxis and at least one tryptase determination. The diagnostic performance of the consensus formula was compared to 5 alternative tryptase interpretation algorithms.
Among 315 patients (median age, 7.8 years; 317 emergency department visits), 175 (55%) were categorized as cases. Food-induced anaphylaxis was diagnosed in 82%, and 92 (52.6%) had two or more tryptase determinations. The highest diagnostic performance was achieved by the sAT/sBT ratio. A cutoff for sAT/sBT ratio of >1.74 yielded 66.7% sensitivity, 90.0% specificity, 96.8% positive predictive value, and 24.3% negative predictive value. The retrospective study design was a major limitation.
Compared to the current consensus formula, a sAT/sBT ratio above 1.74 may enhance the diagnostic performance of dynamic tryptase measurement in children with suspected anaphylaxis.
如果时机和解读恰当,动态测量血清急性(sAT)和基线(sBT)类胰蛋白酶可确认全身过敏反应期间肥大细胞的脱颗粒情况。目前的共识公式要求sAT大于个性化临界值[sAT > (1.2 × sBT) + 2]。仅有少数研究调查了其在儿童中的诊断性能。
我们评估了共识公式及用于解读疑似过敏反应儿科患者类胰蛋白酶水平的替代算法的诊断准确性。
回顾性分析了2011年至2020年转诊至法国马赛大学医院儿科急诊科的疑似过敏反应的病历。收集了临床和实验室数据,包括总类胰蛋白酶和过敏评估。过敏反应被定义为医生评估时突然发作的、被认为危及生命的全身反应。纳入标准为疑似过敏反应且至少进行了一次类胰蛋白酶测定。将共识公式的诊断性能与5种替代类胰蛋白酶解读算法进行了比较。
在315例患者(中位年龄7.8岁;317次急诊科就诊)中,175例(55%)被归类为病例。82%的患者被诊断为食物诱导的过敏反应,92例(52.6%)进行了两次或更多次类胰蛋白酶测定。sAT/sBT比值的诊断性能最高。sAT/sBT比值>1.74时,敏感性为66.7%,特异性为90.0%,阳性预测值为96.8%,阴性预测值为24.3%。回顾性研究设计是一个主要局限性。
与目前的共识公式相比,sAT/sBT比值高于1.74可能会提高动态类胰蛋白酶测量对疑似过敏反应儿童的诊断性能。